Comment on CMS-2026-1255-0001
Healthy Aging CoalitionSupportAdvocacy
Summary: The Healthy Aging Coalition supports the proposed rule but urges CMS to strengthen it by requiring standardized public posting of prior authorization metrics, establishing a centralized public database, and extending transparency requirements to include Medicare Part D drugs. They also advocate for reporting these metrics by specific service categories to better identify patterns of care denial.
The Healthy Aging Coalition respectfully submits the attached comment letter regarding the Centers for Medicare & Medicaid Services' proposed rule, CMS-0062-P, Interoperability Standards and Prior Authorization for Drugs.
The attached letter outlines the Coalition's recommendations to strengthen transparency and accountability in prior authorization reporting. Specifically, we urge CMS to: (1) improve public access to prior authorization data through standardized and centralized reporting; (2) extend meaningful transparency requirements to Medicare Part D prior authorization activities; and (3) require reporting of numeric prior authorization metrics, including reporting by service category to ensure meaningful oversight of access-to-care patterns.
We appreciate the opportunity to provide comments and respectfully request that CMS consider the recommendations contained in the attached letter.
Submitted on behalf of the Healthy Aging Coalition.
Vicki Shepard,CEO/Founder
